Investigators analyzed six sets of patient-derived glioblastoma organoids treated concurrently with the same autologous CAR-T cell products as patients in our phase I study.
[Cell Stem Cell]
Home Newsletters Cell Therapy News Patient-Derived Glioblastoma Organoids as Real-Time Avatars for Assessing Responses to Clinical CAR-T...
